文献速递妇科

子宫内膜癌分子分型与淋巴结转移的存在相关

Endometrial carcinoma molecular subtype correlates with the presence of lymph node metastases.
PubMed 文献 · Gynecol Oncol · 2022-03-02

本研究回顾性分析单中心2015年172例子宫内膜癌初治手术患者,将分子分型与淋巴结转移进行关联分析。分子分型与淋巴结转移显著相关(p=0.004),p53abn型淋巴结转移率最高(44.8%),多因素分析中分子分型和术前CA125>25与淋巴结转移显著相关(p=0.021和p=0.022)。作者认为术前分子分型可指导手术规划,可能减少不必要的淋巴结分期。

要点

  • 分子分型与淋巴结转移显著相关(p=0.004),p53abn型淋巴结转移率44.8%。
  • 多因素分析中分子分型和术前CA125>25与淋巴结转移显著相关(p=0.021和p=0.022)。
  • 术前诊断标本可获得分子分型,作者认为可指导手术规划并可能减少不必要淋巴结分期的费用和并发症。

核心结论

  • 子宫内膜癌分子分型与淋巴结转移的存在显著相关。
  • 分子分型可在术前诊断标本上获得,作者认为该信息可用于指导手术治疗规划,并可能减少子宫内膜癌诊疗中不必要的淋巴结分期所带来的费用和并发症。

研究设计与样本

  • 回顾性分析单中心2015日历年所有接受初次分期手术并计划完成盆腔±腹主动脉旁淋巴结清扫的子宫内膜癌患者,共纳入172例,结合临床病理和结局数据回顾性分配分子分型。

主要发现

  • 全队列分子分型为POLEmut 21例(12.2%)、MMRd 47例(27.3%)、NSMP 74例(43.1%)、p53abn 30例(17.4%)。
  • 172例中171例完成盆腔±腹主动脉旁淋巴结清扫,31/171例(18.1%)发现淋巴结转移,包括大转移19/31、微转移5/31、孤立肿瘤细胞7/31。
  • 淋巴结转移仅盆腔者占83.9%,盆腔加腹主动脉旁者占16.1%,无孤立腹主动脉旁淋巴结转移。
  • 分子分型与淋巴结转移显著相关(p=0.004);p53abn型淋巴结转移率44.8%,POLEmut型14.2%,MMRd型14.9%,NSMP型10.8%。
  • 多因素分析中分子分型和术前CA125>25与淋巴结转移显著相关(p=0.021和p=0.022),而术前分级和组织学类型不显著(p=0.24)。

临床怎么用

  • 作者认为术前分子分型可指导手术治疗规划,并可能减少不必要的淋巴结分期所带来的费用和并发症。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The role of lymph node assessment/dissection (LND) in endometrial cancer (EC) has been debated for decades, with significant practice variation between centers. Molecular classification of EC provides prognostic information and can be accurately performed on preoperative endometrial biopsies. We assessed the association between molecular subtype and lymph node metastases (LNM) in order to determine if this tool could be used to stratify surgical decision making. METHODS: All EC patients undergoing primary staging surgery with planned complete pelvic +/- para-aortic LND from a single institution in the 2015 calendar year were identified, with clinicopathological and outcome data assessed in the context of retrospectively assigned molecular classification. RESULTS: 172 patients were included. Molecular classification of the total cohort showed 21 POLEmut (12.2%), 47 MMRd (27.3%), 74 NSMP (43.1%), and 30 p53abn (17.4%) ECs. Complete pelvic +/- para-aortic LND was performed in 171 of 172 patients, and LNM were found in 31/171 (18.1%). This included macrometastases (19/31), micrometastases (5/31), and isolated tumour cells (ITCs) (7/31). LNM were pelvic only in 83.9%, and pelvic plus para-aortic in 16.1%. There were no isolated para-aortic LNM. Molecular subtype was significantly associated with LNM (p = 0.004). There was a strong association between the presence of LNM and p53abn EC (nodal involvement in 44.8% of cases), with LNM detected in 14.2% of POLEmut, 14.9% of MMRd, and 10.8% of NSMP EC. On multivariate analysis, molecular subtype and preoperative CA 125 > 25 were significantly associated with LNM (p = 0.021 and p = 0.022 respectively) but preoperative grade and histotype were not (p = 0.24). CONCLUSION: EC molecular subtype is significantly associated with the presence of LNM. As molecular classification can be obtained on preoperative diagnostic specimens, this information can be used to guide surgical treatment planning and may reduce the cost and morbidity of unnecessary lymph node staging in EC care.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Jamieson A, Thompson EF, Huvila J, et al. Endometrial carcinoma molecular subtype correlates with the presence of lymph node metastases. Gynecol Oncol. 2022. PMID: 35504673. doi:10.1016/j.ygyno.2022.01.025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。